Vitamin K AntagonISt, Factor Xa Inhibitor Or Nothing In Atrial Fibrillation And DIalytic End-stage Renal DiseasE (VISIONAIRE)
Conditions: Atrium; Fibrillation; Chronic Kidney Diseases Interventions: Drug: Oral anticoagulant Sponsors: Hospital Sirio-Libanes; Daiichi Sankyo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 7, 2024 Category: Research Source Type: clinical trials
The Role of Vitamin K on Knee Osteoarthritis Outcomes
Conditions: Osteo Arthritis Knee Interventions: Dietary Supplement: Vitamin K1 500 µg; Dietary Supplement: K1 1000 µg; Dietary Supplement: Vitamin K2 (MK-7) 360 µg; Other: Placebo Sponsors: Boston University; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Use of ETElcalcetidefor pReserving vitamiN K-dependent proteIn activiTY ITAlian Study
Conditions: Hemodialysis Sponsors: Istituto di Fisiologia Clinica CNR Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma
Conditions: Liver Transplantation; Hepatocellular Carcinoma; Alpha-Fetoprotein; Protein Induced by Vitamin K Absence or Antagonist-II Sponsors: Zhejiang University; Shulan (Hangzhou) Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
High Vitamin K Intake Diet Intervention Effect on Cardiovascular Risk Percentage in Young Adults
Conditions: Overweight and Obesity Interventions: Other: vitamin K diet Sponsors: University of Guadalajara Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants Concentration Among Patients With Acute Stroke (The Direct Oral AntiCoagulant Registry in Taiwan-Emergent Department, DOACT-ED)
Conditions: Assess the Stroke Outcome in DOAC Users Who Suffered From Ischemic Stroke or Intracranial Hemorrhage Interventions: Drug: Dabigatran, rivaroxaban, apixaban, edoxaban Sponsors: National Taiwan University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma
Condition: Cancer of Liver Intervention: Other: No intervention Sponsor: Zhejiang University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2023 Category: Research Source Type: clinical trials
